TrialCritical care (London, England)2021

Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.

Fabienne Venet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.